论文部分内容阅读
目的:对糖尿病肾病患者肾功能检验指标的相关临床价值进行分析对比。方法:将于我院治疗的65例患有糖尿病的患者作为此次探究分析的对象,并按照患者肾病的实际情况进行分组,即实验组(肾病)及对照组(非肾病),其中,两组例数分别为33例与32例;给予两组全部患者行肾功能的相关检查,对比分析两组的各项临床指标。结果:对照组的Scr(血清肌酐)、BUN(尿素氮)、m ALB(尿微量白蛋白)的水平均明显比研究组低,且P<0.05,有统计学差异存在。结论:m ALB及Scr、BUN均可作为诊断糖尿病肾病的临床指标,并能及时发现患者糖尿病的发生及进展,从而为患者后续的治疗提供重要的依据。
Objective: To analyze and compare the clinical value of renal function test in patients with diabetic nephropathy. Methods: Sixty-five patients with diabetes mellitus treated in our hospital were enrolled in this study. Patients were divided into experimental group (nephropathy) and control group (non-nephropathy) according to the actual situation of patients with nephropathy. Among them, The number of cases were 33 cases and 32 cases respectively. All the patients in both groups were given renal function tests, and the clinical indicators of both groups were compared. Results: The levels of Scr (serum creatinine), BUN (urea nitrogen) and m ALB (urine microalbumin) in the control group were significantly lower than those in the study group, and P <0.05. There was a statistically significant difference. Conclusion: Both m ALB, Scr and BUN can be used as clinical indicators in the diagnosis of diabetic nephropathy, and can promptly detect the occurrence and progression of diabetes mellitus, thus providing an important basis for the follow-up of patients.